InterWell Health, an organization of neuroscientists, has teamed up with Fresenius Health Partners and Cricket Health, the company announced on Wednesday.
The new company will operate under the name InterWell Health and is expected to manage the care of more than 270,000 patients with kidney disease and reach $11 billion in medical expenses under management by 2025. Initially, the new venture was estimated at $2.4 billion and the costs were approximately $6 billion. under management and over 100,000 lives. Fresenius Health Partners was the cost-based parent company of Fresenius Medical Care and Cricket Health is the provider of the data platform. Companies announced a merger in March.
“In a value-based world, it’s no longer enough to just provide quality care – providers need to help patients change behavior, and that requires a fundamental change in how we interact with patients,” said Robert Sepucha, CEO of InterWell, who previously led Cricket. in the news release.
Former Fresenius chief executive David Pollack is Interwell’s president and chief operating officer, while Dr. George Hart, a nephrologist, is the chief medical officer.
Financial details of the deal were not disclosed, and Interwell did not immediately respond to an interview request.
InterWell’s investors include Fresenius Medical Care, Welsh, Carson, Anderson & Stowe’s Valtruis, Oak HC/FT, Cigna Ventures and Blue Shield of California.